Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 16/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19497251 | 0.96 | POLB (0.35) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL20252387 | 0.90 | POLB (0.35) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL18473137 | 0.89 | POLB (0.34) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL21841985 | 0.89 | POLB (0.34) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL19497305 | 0.89 | POLB (0.34) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL20275212 | 0.88 | POLB (0.36) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL19497312 | 0.87 | BACE1 (0.45) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL15495194 | 0.87 | POLB (0.40) | POLBAPEX1HTTTDP1FFAR4 | |
| SCHEMBL22592264 | 0.86 | POLB (0.39) | POLBAPEX1HTTTDP1 | |
| SCHEMBL19559099 | 0.86 | POLB (0.39) | POLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3663378-A1 | LIQUID CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2020-06-10 | — | — | EP | disclosed |
| EP-2957618-B1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2018-08-01 | — | — | EP | disclosed |